Cat.No：GM-59269AB
Product：Anti-NKP30 hIgG1 Antibody(BJM-0411)
Cat.No：GM-59269AB
Product：Anti-NKP30 hIgG1 Antibody(BJM-0411)
GM-59269AB-10 10 μg
GM-59269AB-100 100 μg
GM-59269AB-1000 1 mg
Species Reactivity Human; Cynomolgus
Clone BJM-0411
Source/Isotype Monoclonal human IgG1, κ
Application Flow cytometry; Activation assay ;
Specificity Detects NKP30
Gene NKP30
Other Names NCR3, 1C7, CD337, LY117, MALS, NKCR3
Gene ID 259197(human); 102133932(Cynomolgus)
Background NKP30 is a natural killer cell receptor, belonging to the NCR family. It plays a crucial role in natural killer cells (NK cells) by interacting with ligands on the surface of tumor cells, participating in the regulation of NK cell activation and cytotoxicity. Research on NKP30 can help us gain a deeper understanding of the immune regulation mechanisms of NK cells and their potential applications in tumor immunotherapy. In cancer immunotherapy research, the activation of NKP30 can enhance the killing of tumor cells by NK cells, making it a promising target for future cancer treatments.
Storage Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.
Formulation Phosphate-buffered solution, pH 7.2.
Endotoxin < 1 EU/mg, determined by LAL gel clotting assay
Flow cytometry Cynomolgus_NKP30 CHO-K1 Cell Line (Catalog # GM-C33009) was stained with Anti-NKP30 hIgG1 Antibody(BJM-0411) (Catalog # GM-59269AB) or isotype control antibody, followed by anti-Human IgG APC-conjugated Secondary Antibody.
Cat.No：GM-59269AB
Product：Anti-NKP30 hIgG1 Antibody(BJM-0411)
GM-59269AB-10 10 μg
GM-59269AB-100 100 μg
GM-59269AB-1000 1 mg
Species Reactivity Human; Cynomolgus
Clone BJM-0411
Source/Isotype Monoclonal human IgG1, κ
Application Flow cytometry; Activation assay ;
Specificity Detects NKP30
Gene NKP30
Other Names NCR3, 1C7, CD337, LY117, MALS, NKCR3
Gene ID 259197(human); 102133932(Cynomolgus)
Background NKP30 is a natural killer cell receptor, belonging to the NCR family. It plays a crucial role in natural killer cells (NK cells) by interacting with ligands on the surface of tumor cells, participating in the regulation of NK cell activation and cytotoxicity. Research on NKP30 can help us gain a deeper understanding of the immune regulation mechanisms of NK cells and their potential applications in tumor immunotherapy. In cancer immunotherapy research, the activation of NKP30 can enhance the killing of tumor cells by NK cells, making it a promising target for future cancer treatments.
Storage Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.
Formulation Phosphate-buffered solution, pH 7.2.
Endotoxin < 1 EU/mg, determined by LAL gel clotting assay
Flow cytometry Cynomolgus_NKP30 CHO-K1 Cell Line (Catalog # GM-C33009) was stained with Anti-NKP30 hIgG1 Antibody(BJM-0411) (Catalog # GM-59269AB) or isotype control antibody, followed by anti-Human IgG APC-conjugated Secondary Antibody.
